US Patent Issued to FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION on June 30 for "Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors" (Florida, District Of Columbia Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,558, issued on June 30, was assigned to FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION INC. (Tallahassee, Fla.).

"Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors" was invented by Eric Holmes (Tallahassee, Fla.), Gary Ostrander (Tallahassee, Fla.) and Geoffrey Stuart Dow (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns the use of an alpha-glucosidase glycoprotein processing inhibitor for the treatment or prevention of human coronavirus infections, such as SARS-CoV-2 or SARS-CoV-2 variant infections. Aspects of the invention include methods for treating or prev...